Sotagliflozin in patients with diabetes and chronic kidney disease
- Deepak L. Bhatt*
- , Michael Szarek
- , Bertram Pitt
- , Christopher P. Cannon
- , Lawrence A. Leiter
- , Darren K. McGuire
- , Julia B. Lewis
- , Matthew C. Riddle
- , Silvio E. Inzucchi
- , Mikhail N. Kosiborod
- , David Z.I. Cherney
- , Jamie P. Dwyer
- , Benjamin M. Scirica
- , Clifford J. Bailey
- , Rafael Díaz
- , Kausik K. Ray
- , Jacob A. Udell
- , Renato D. Lopes
- , Pablo Lapuerta
- , P. Gabriel Steg
*Corresponding author for this work
- Harvard University
- Colorado Prevention Center
- State University of New York Downstate
- University of Michigan
- Li Ka Shing Knowledge Institute
- University of Texas at Dallas
- Vanderbilt University Medical Center
- Oregon Health and Science University
- Yale University
- University of Missouri-Kansas City
- University Health Network University of Toronto
- Instituto Cardiovascular de Rosario
- Royal Brompton Hospital
- University Health Network
- Duke Clinical Research Institute
- Lexicon Pharmaceuticals
- Institut National de la Santé et de la Recherche Médicale
Research output: Contribution to journal › Article › peer-review
1073
Link opens in a new tab
Citations
(SciVal)
25
Downloads
(Pure)